The study found that verapamil is a potentially beneficial drug for newly diagnosed T1D individuals and promotes beta-cell function, delays beta-cell loss, and helps reduce insulin requirements and hypoglycemic episodes [24]. This evidence concerns the gene INS and type 1 diabetes mellitus.